Article citationsMore>>

Kilic, S., Pinarli, F., Ozogul, C., Tasdemir, N., Naz Sarac, G. and Delibasi, T. (2013) Protection from Cyclophosphamide-Induced Ovarian Damage with Bone Marrow-Derived Mesenchymal Stem Cells during Puberty. Gynecological Endocrinology, 30, 135-140.
https://doi.org/10.3109/09513590.2013.860127

has been cited by the following article:

• TITLE: Current Status of Stem Cells in the Treatment of Premature Ovarian Failure

  AUTHORS: Guojie Ji, Huanhuan Hu, Rui Liu, Guanjie Li, Jiangshan Zhao, Huigen Feng

  KEYWORDS: Etiology, Infertility, Premature Ovarian Failure, Regenerative Medicine, Stem Cells

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.7, July 24, 2024

  ABSTRACT: Premature ovarian failure (POF) is a prevalent cause of female infertility. POF features include estrogen hypofunction, amenorrhea, infertility, and high gonadotropin levels. The etiology of POF is genetic diseases, autoimmune diseases, enzyme defects and environmental factors. The development of Regenerative medicine has made stem cell and exosome (EXOs) therapy effective for POF. This review discusses POF stem cell research and development.